Laxai Biopharma Profile
Key Indicators
- Authorised Capital ₹ 4.75 Cr
- Paid Up Capital ₹ 3.89 Cr
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.00 Cr
- Revenue Growth -90.69%
- Profit Growth -1413.28%
- Ebitda -1413.28%
- Net Worth -0.05%
- Total Assets -0.00%
About Laxai Biopharma
Laxai Biopharma Private Limited (LBPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 July 2015 (Nine years and six months 28 days old ). Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Osr Hazardous Waste Management Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.75 Cr and a paid-up capital of Rs 3.89 Cr.
The company currently has active open charges totaling ₹25.00 Cr.
Lavanya Gali and Nagajayanthi Juttur serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2015PTC099707
-
Company No.
099707
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jul 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Laxai Biopharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lavanya Gali
|
Director | 07-Apr-2017 | Current |
Nagajayanthi Juttur
|
Director | 30-Mar-2023 | Current |
Financial Performance of Laxai Biopharma.
Laxai Biopharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 90.69% decrease. The company also saw a substantial fall in profitability, with a 1413.28% decrease in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laxai Biopharma?
Unlock access to Laxai Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sleepcare Solutions Private LimitedLavanya Gali is a mutual person
-
Laxai Life Sciences Private LimitedLavanya Gali is a mutual person
-
Resquip Medical Equipments LlpLavanya Gali is a mutual person
-
Clinovo (India) Llp
Lavanya Gali is a mutual person
-
Emev Private Limited
Lavanya Gali is a mutual person
Charges (Loans)
₹25.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 25.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2024 | Others | ₹25.00 Cr | Open |
How Many Employees Work at Laxai Biopharma?
Unlock and access historical data on people associated with Laxai Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laxai Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laxai Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
